StockData
Bionano Genomics, Inc. logo

Bionano Genomics, Inc. (BNGO) stock

BNGONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 12/3083% below fair value
$0.95+0.01 (+1.29%)

Close on Nov 17, 2026Market cap $11.21MP/E –Yield –

Bionano Genomics cash

Cash and short-term investments held at the end of each period.

Bionano Genomics's cash was $9.92M at Jun 30, 2026. For fiscal 2025 it was $19.27M, up 103.4% from the year before. The highest annual figure on record is $250.61M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$19.27M+103.4%
FY2024Dec 31, 2024$9.48M-85.8%
FY2023Dec 31, 2023$66.77M-41.0%
FY2022Dec 31, 2022$113.19M-54.8%
FY2021Dec 31, 2021$250.61M+551.8%
FY2020Dec 31, 2020$38.45M+122.1%
FY2019Dec 31, 2019$17.31M+4.8%
FY2018Dec 31, 2018$16.52M+1516.9%
FY2017Dec 31, 2017$1.02M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$9.92M-39.7%
Q1 FY2026Mar 31, 2026$14.41M-21.0%
Q4 FY2025Dec 31, 2025$19.27M+103.4%
Q3 FY2025Sep 30, 2025$21.58M+80.5%
Q2 FY2025Jun 30, 2025$16.44M-13.2%
Q1 FY2025Mar 31, 2025$18.23M-35.6%
Q4 FY2024Dec 31, 2024$9.48M-85.8%
Q3 FY2024Sep 30, 2024$11.95M-81.2%
Q2 FY2024Jun 30, 2024$18.94M-75.4%
Q1 FY2024Mar 31, 2024$28.32M-70.4%
Q4 FY2023Dec 31, 2023$66.77M-41.0%
Q3 FY2023Sep 30, 2023$63.58M-64.7%
Q2 FY2023Jun 30, 2023$77.06M-58.9%
Q1 FY2023Mar 31, 2023$95.81M-55.7%
Q4 FY2022Dec 31, 2022$113.19M-54.8%
Q3 FY2022Sep 30, 2022$180.19M-44.7%
Q2 FY2022Jun 30, 2022$187.34M-43.7%
Q1 FY2022Mar 31, 2022$216.47M-40.2%
Q4 FY2021Dec 31, 2021$250.61M+551.8%
Q3 FY2021Sep 30, 2021$326.07M+1628.3%
Q2 FY2021Jun 30, 2021$332.55M+1834.1%
Q1 FY2021Mar 31, 2021$362.06M+4345.7%
Q4 FY2020Dec 31, 2020$38.45M+122.1%
Q3 FY2020Sep 30, 2020$18.87M+129.4%
Q2 FY2020Jun 30, 2020$17.19M+12.4%
Q1 FY2020Mar 31, 2020$8.14M-60.9%
Q4 FY2019Dec 31, 2019$17.31M+4.8%
Q3 FY2019Sep 30, 2019$8.23M-60.2%
Q2 FY2019Jun 30, 2019$15.30M+1396.7%
Q1 FY2019Mar 31, 2019$20.83M–
Q4 FY2018Dec 31, 2018$16.52M–
Q3 FY2018Sep 30, 2018$20.66M–
Q4 FY2017Dec 31, 2017$1.02M–

More Bionano Genomics figures

See a number that looks wrong?